267 related articles for article (PubMed ID: 15250239)
1. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris.
Bisht H; Chugh DA; Swaminathan S; Khanna N
Protein Expr Purif; 2001 Oct; 23(1):84-96. PubMed ID: 11570849
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
4. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
6. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen.
Lünsdorf H; Gurramkonda C; Adnan A; Khanna N; Rinas U
Microb Cell Fact; 2011 Jun; 10():48. PubMed ID: 21703024
[TBL] [Abstract][Full Text] [Related]
8. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
10. Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay.
Touze A; Enogat N; Buisson Y; Coursaget P
J Clin Microbiol; 1999 Feb; 37(2):438-41. PubMed ID: 9889237
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris using the GAP promoter.
Vassileva A; Chugh DA; Swaminathan S; Khanna N
J Biotechnol; 2001 Jun; 88(1):21-35. PubMed ID: 11377762
[TBL] [Abstract][Full Text] [Related]
12. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris].
Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.
Liu R; Lin Q; Sun Y; Lu X; Qiu Y; Li Y; Guo X
Appl Biochem Biotechnol; 2009 Aug; 158(2):432-44. PubMed ID: 19184543
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
[TBL] [Abstract][Full Text] [Related]
17. [Secretion expression in Pichia pastoris and immunogenicity comparison of two forms of HBsAg/GM-CSF fusion proteins].
Yi S; Xi XR; Shi R; Yang F; Li M; Li DF; Sun MS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):894-7. PubMed ID: 17908492
[TBL] [Abstract][Full Text] [Related]
18. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a yeast-based VLP platform for antigen presentation.
Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
[TBL] [Abstract][Full Text] [Related]
20. Novel membrane extraction procedure for the purification of hepatitis B surface antigen from Pichia pastoris.
Patil A; Khanna N
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():7-14. PubMed ID: 22608354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
